Description
Parkinson’s disease (PD) is a debilitating neurodegenerative disorder, triggered by the death of dopamine neurons in the brain region known as the substantia nigra. Whilst the mechanisms underlying dopamine cell loss in PD, it is clear that males are more susceptible to PD than females. We have identified that the male sex-determining gene SRY directs a novel genetic mechanism of dopamine cell death in males. Understanding when and how SRY increases the vulnerability of male dopamine neurons to injury will help explain why males are more susceptible to the PD and to identify SRY as a novel target for neuroprotective therapy in male PD patients.
1. Lee J, Pinares-Garcia P, Loke H, Ham S, Vilain E,Harley V (2019) Sex-specific neuroprotection by inhibition of the Y-chromosome gene, SRY, in experimental Parkinson’s disease. PNAS 116(33):16577-16582.
Essential criteria:
Minimum entry requirements can be found here: https://www.monash.edu/admissions/entry-requirements/minimum
Keywords
parkinson's disease, brain differences, sex differences, SRY
School
School of Clinical Sciences at Monash Health / Hudson Institute of Medical Research » Molecular and Translational Sciences
Available options
PhD/Doctorate
Masters by research
Honours
BMedSc(Hons)
Time commitment
Full-time
Top-up scholarship funding available
No
Physical location
Monash Health Translation Precinct (Monash Medical Centre)
Co-supervisors
Prof
Vincent Harley